about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

FDA meet­ing to pick next win­ter's flu shot is can­celed, in omi­nous sign for US vac­cine pol­i­cy

3 months ago
Pharma
FDA+

Medicare spend­ing on com­mon di­a­betes drugs sky­rock­et­ed, HHS in­spec­tor gen­er­al finds

3 months ago
Pharma

Com­pounders sue FDA over re­moval of semaglu­tide from of­fi­cial short­age list

3 months ago
FDA+
Law

Mer­ck KGaA tees up changes to lead­er­ship team; Ex-CVS Health CEO joins Ther­mo Fish­er’s board

3 months ago
Peer Review

First meet­ing of CDC vac­cine ad­vi­sors in the Kennedy era is post­poned

3 months ago
FDA+

No­vo looks to re­coup $830M from hy­per­ten­sion drug part­ner, claim­ing fraud

3 months ago
Pharma
Law

GSK fol­lows Pfiz­er in meningo­coc­cal vac­cine race with new FDA nod

3 months ago
Pharma
FDA+

Up­dat­ed: Mod­er­na re­ports $238M man­u­fac­tur­ing write-down as cuts, new vac­cines shape 2025

3 months ago
Pharma
Manufacturing

Novo's weight loss drug helps curb some drink­ing habits, small study shows

3 months ago
R&D

Spring­Works lands FDA ap­proval for nerve tu­mor treat­ment

3 months ago
R&D
Pharma

Mer­ck KGaA con­firms in­ter­est in ac­quir­ing can­cer biotech Spring­Works

3 months ago
R&D
Pharma

Ab­b­Vie wins FDA ap­proval for new an­tibi­ot­ic to treat com­plex in­tra-ab­dom­i­nal in­fec­tions

3 months ago
Pharma
FDA+

Up­dat­ed: Bay Area biotech VC to shut down 15 months af­ter launch, sources say, af­ter key in­vestor pulls out

3 months ago
People
Financing

Bris­tol My­ers prunes pipeline amid new round of cost cuts

3 months ago
Pharma

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

3 months ago
Deals
Pharma

Up­dat­ed: RFK Jr. ad­vances out of Sen­ate com­mit­tee with Cas­sidy’s sup­port

3 months ago
People
FDA+

Up­dat­ed: Pfiz­er sticks to 2025 pro­jec­tions as Covid sales sta­bi­lize, R&D re­vamp con­tin­ues

3 months ago
Pharma

Bio­gen’s re­vised re­search strat­e­gy is to avoid be­com­ing ob­so­lete, top ex­ec says

3 months ago
Deals
R&D

RFK Jr. evades ques­tions on vac­cines and autism in writ­ten re­spons­es to sen­a­tors

4 months ago
People
FDA+

Roche sep­a­rates CFO, in­for­mat­ics posts; Lil­ly ex­ecs land at Kail­era, Neu­ro­crine

4 months ago
Peer Review

Re­gen­eron wins ap­peals court or­ders back­ing halt on Eylea biosim­i­lars

4 months ago
Pharma
Law

Phar­ma­cy mid­dle­men lose bid to toss new Hawaii com­plaint

4 months ago
Pharma
Law

Sage turns down Bio­gen's buy­out of­fer and will look at oth­er op­tions

4 months ago
Deals
Pharma

Veru's drug lessens loss of lean mass in pa­tients tak­ing We­govy

4 months ago
R&D
First page Previous page 1234567 Next page Last page
A service from the Financial Times